Fri, October 25, 2019
Thu, October 24, 2019
Wed, October 23, 2019

Jay Olson Initiated (ACAD) at Hold and Held Target at $44 on, Oct 24th, 2019

Jay Olson of Oppenheimer, Initiated "ACADIA Pharmaceuticals Inc." (ACAD) at Hold and Held Target at $44 on, Oct 24th, 2019.

Jay has made no other calls on ACAD in the last 4 months.



There are 6 other peers that have a rating on ACAD. Out of the 6 peers that are also analyzing ACAD, 1 agrees with Jay's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Paul Matteis of "Stifel" Maintained at Hold with Increased Target to $28 on, Tuesday, September 3rd, 2019


These are the ratings of the 5 analyists that currently disagree with Jay


  • Gregory Renza of "RBC Capital" Initiated at Buy and Held Target at $60 on, Tuesday, October 1st, 2019
  • Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $56 on, Monday, September 23rd, 2019
  • Marc Goodman of "SVB Leerink" Upgraded from Hold to Buy and Increased Target to $50 on, Friday, September 13th, 2019
  • Sumant Kulkarni of "Canaccord Genuity" Upgraded from Hold to Strong Buy on, Tuesday, September 10th, 2019
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $60 on, Monday, September 9th, 2019